Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain - PubMed (original) (raw)
Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain
T Scharton-Kersten et al. Exp Parasitol. 1996 Nov.
Free article
Abstract
Immunity in mice infected with Toxoplasma gondii is dependent upon the ability to generate protective levels of the cytokine IFN-gamma. In this report, we present evidence that the attenuated vaccine strain, ts-4, induces the latter cytokine by both IL-12-dependent and -independent pathways. In contrast, strain ME49 appears to induce IFN-gamma wholly in dependence upon IL-12. Thus, 88% of wildtype C57BL/6 mice treated with anti-IL-12 mAb survive ts-4 infection, unlike similarly treated ME49-infected animals. Moreover, while anti-IL-12 treatment reduced early IFN-gamma and nitric oxide production to background levels in ts-4-infected scid animals, the same treatment in infected C57BL/6 mice had no effect on production of the latter mediators. In addition, we found that anti-IL-12 treatment induces 100% mortality in CD(4+)-deficient MHC class II knockout mice infected with ts-4. Finally, production of nitric oxide (a molecule implicated in parasite control) was abrogated in ts-4-infected scid mice following depletion of IFN-gamma producing NK cells. Together, our results suggest that ts-4 induces IL-12-dependent and -independent IFN-gamma production in normal mice, but ME49 induces the latter cytokine only in dependence upon IL-12. Our data, furthermore, implicate involvement of T cells in the IL-12-independent component of the IFN-gamma response.
Similar articles
- In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A. Scharton-Kersten TM, et al. J Immunol. 1996 Nov 1;157(9):4045-54. J Immunol. 1996. PMID: 8892638 - Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
Yap GS, Sher A. Yap GS, et al. Immunobiology. 1999 Dec;201(2):240-7. doi: 10.1016/S0171-2985(99)80064-3. Immunobiology. 1999. PMID: 10631573 Review. - T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii.
Denkers EY. Denkers EY. Microbes Infect. 1999 Jul;1(9):699-708. doi: 10.1016/s1286-4579(99)80071-9. Microbes Infect. 1999. PMID: 10611747 Review.
Cited by
- P18 (SRS35/TgSAG4) Plays a Role in the Invasion and Virulence of Toxoplasma gondii.
Hamie M, Tawil N, El Hajj R, Najm R, Moodad S, Hleihel R, Karam M, El Sayyed S, Besteiro S, El-Sabban M, Dubremetz JF, Lebrun M, El Hajj H. Hamie M, et al. Front Immunol. 2021 Jun 28;12:643292. doi: 10.3389/fimmu.2021.643292. eCollection 2021. Front Immunol. 2021. PMID: 34262559 Free PMC article. - Transcriptional Regulation of Natural Killer Cell Development and Functions.
Wang D, Malarkannan S. Wang D, et al. Cancers (Basel). 2020 Jun 16;12(6):1591. doi: 10.3390/cancers12061591. Cancers (Basel). 2020. PMID: 32560225 Free PMC article. Review. - Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance.
Hashemi E, Malarkannan S. Hashemi E, et al. Cancers (Basel). 2020 Jun 12;12(6):1553. doi: 10.3390/cancers12061553. Cancers (Basel). 2020. PMID: 32545516 Free PMC article. Review. - Protozoan Parasites and Type I IFNs.
Silva-Barrios S, Stäger S. Silva-Barrios S, et al. Front Immunol. 2017 Jan 19;8:14. doi: 10.3389/fimmu.2017.00014. eCollection 2017. Front Immunol. 2017. PMID: 28154565 Free PMC article. Review. - CD8+ T Cell Responses to Plasmodium and Intracellular Parasites.
Villarino N, Schmidt NW. Villarino N, et al. Curr Immunol Rev. 2013 Aug;9(3):169-178. doi: 10.2174/1573395509666131126232327. Curr Immunol Rev. 2013. PMID: 24741372 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials